author-photo

Anna Asklid

Karolinska University Hospital

10

Papers

30

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

A real-world study of first-line therapy in 280 consecutive Swedish patients ≥80 years with newly diagnosed diffuse large B-cell lymphoma: very elderly (≥85 years) do well on curative intended therapy

2020 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (3)
Real-world studies on B-cell malignancies

2020
- Anna Asklid
Show All
- Source
- Cite
- Save
Citations (0)
Risk‐adapted bendamustine + rituximab is a tolerable treatment alternative for elderly patients with chronic lymphocytic leukaemia: a regional real‐world report on 141 consecutive Swedish patients

2020 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (2)
Ibrutinib versus previous standard of care: an adjusted comparison in patients with relapsed/refractory chronic lymphocytic leukaemia

2017 Annals of Hematology
Show All
- Source
- Cite
- Save
Citations (9)
Real-World Results on Ibrutinib in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) : Data from 97 Swedish Patients Treated in a Compassionate Use Program

2015 Blood
Show All
- Source
- Cite
- Save
Citations (6)
Outcome of Second Line Treatment in Patients with Chronic Lymphocytic Leukemia Did Not Improve 2002-2013: A Population-Based Study from a Well-Defined Geographic Region

2015 Blood
Show All
- Source
- Cite
- Save
Citations (1)